- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02686203
Evaluate the Effectiveness of Low Level Laser Therapy (LLT) Combined With Acupuncture
A Feasibility Study to Evaluate the Effectiveness of Low Level Laser Therapy Combined With Acupuncture as Palliative Treatment of Patients With Various Solid Malignancies Who Are no Longer Candidates for Active Oncological Therapies
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
evaluating The Investigational Therapy effects on quality of life, pain and patient's clinical status in adult cancer patients with solid tumors who are no longer candidates for active oncological therapies.
Eligible patients will be enrolled into the study and receive at least two 20-min treatment sessions, 2 to 12 weeks apart, with the Investigational Therapy on healthy body tissue (i.e. non-tumor region) of back of the hand and/or foot. Number of treatment sessions and treatment frequency will be individualized per patient depending on patient's status as well as per the discretion of the treating therapist, who is specialized and experienced with using the Investigational Therapy. Patients will be assessed for quality of life, pain and patient's clinical status according to acceptable clinical evaluations.
If at any time after the start of this study, it will be decided to initiate active oncological treatment, the principal investigator or designee will inform the Sponsor. The Sponsor will decide if the patient will stay or be discontinued from the study.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Michael schlosser
- Phone Number: +972-54-4777307
- Email: Michael@gd-energis.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Male and female patients 18 to 70 years of age diagnosed with cancer (with or without metastasis) including but not limited to breast, ovarian, cervical, uterine, renal, bladder, gastric, pancreas, lung, thyroid, colorectal, small and large intestine, testicle and prostate cancer who have either
- failed standard treatment for their type of cancer
- decline standard treatment and interested in non-invasive treatment or change in life style
- have time to decide on treatment options and interested in non-invasive treatment
- Confirm cancer diagnosis using biopsy, biomarkers or imaging (PET/CT, MRI, CT, Ultrasound, etc.)
- Karnofsky performance status score of at least 60% for lung cancer and at least 50% for all other cancers at the screening visit
- Life expectancy of at least 12 weeks
Patients must have adequate organ function as defined below:
- AST (SGOT)/ALT(SGPT) <3x upper limit of normal (ULN).
- Serum creatinine <2.0 mg/dL.
- Serum bilirubin <3 mg/dL
- Signed written informed consent to participate in the study independently by patient.
- Ability to comply with the requirements of the study.
Exclusion Criteria:
- Participation in an interventional investigational trial within 30 days of the screening visit.
- Receipt of chemotherapy or radiotherapy within 1 month of the screening visits
- Patients with other concurrent severe and/or uncontrolled medical condition which could compromise participation in the study or interfere with the evaluation of the investigational therapy effect (i.e. active infection, uncontrolled diabetes, uncontrolled hypertension, congestive cardiac failure, unstable angina, ventricular arrhythmias, active ischemic heart disease, myocardial infarction within six months, chronic liver or renal disease, active upper gastrointestinal tract ulceration).
- Any form of substance abuse (including drug or alcohol abuse), psychiatric disorder or any chronic condition susceptible, in the opinion of the investigator or the sponsor, of interfering with the conduct of the study.
- who are likely to be non-compliant or uncooperative during the study. -
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: B-Cure Laser Pro and needles
Treatment will consist of acupuncture applied by a combination of B-Cure Laser Pro, an approved handheld, portable device emitting low level laser, and needles using two to four acupoints (The Investigational Therapy). The Investigational Therapy will be administered by a treating therapist designated by the Sponsor who is experienced in employing the treatment. |
Treatment will consist of acupuncture applied by a combination of B-Cure Laser Pro, an approved handheld, portable device emitting low level laser, and needles using two to four acupoints (The Investigational Therapy). The Investigational Therapy will be administered by a treating therapist designated by the Sponsor who is experienced in employing the treatment |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality of life using World Health Organization Quality of Life questionnaire (WHOQoL-BREF)
Time Frame: 3 months
|
After treatment Quality of life will be measured by using World Health Organization Quality of Life questionnaire (WHOQoL-BREF)
|
3 months
|
Quality of life using patient questionnaire Karnofsky performance status
Time Frame: 3 months
|
After treatment Quality of life will be measured by using patient questionnaire Karnofsky performance status
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Self-reported pain perception using SF-MPQ
Time Frame: 3 months
|
After treatment pain perception will be measured by using Self-reported pain perception using SF-MPQ
|
3 months
|
Self-reported pain perception using pain diagram
Time Frame: 3 months
|
After treatment pain perception be measured by using pain diagram
|
3 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Safety Outcome - Adverse events related to Investigational therapy
Time Frame: 3 months
|
Adverse events related to Investigational therapy
|
3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ido Wolf, MD, head of Medical Oncology Unit Sourasky Medical Center
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- GD-IP-101
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
University of Michigan Rogel Cancer CenterRecruitingCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterHyundai Hope On WheelsRecruitingCancer | Pediatric Cancer | Survivorship | Cancer MetastaticUnited States
-
Vanderbilt-Ingram Cancer CenterNational Institutes of Health (NIH)Active, not recruitingAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
MiRXES Pte LtdRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver CancerSingapore
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedStage I Breast Cancer | Stage I Uterine Corpus Cancer | Stage II Uterine Corpus Cancer | Stage III Uterine Corpus Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage... and other conditionsUnited States
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkCompletedGastric Cancer | Pancreatic Cancer | Esophageal Cancer | Rectal Cancer | Colon Cancer | Hepatobiliary CancerUnited States
-
Johns Hopkins UniversityNational Cancer Institute (NCI); National Institute on Minority Health and...Enrolling by invitationCancer | Advanced Cancer | End Stage Cancer | MalignancyUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
Case Comprehensive Cancer CenterCompletedStage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Stage IVA Colon Cancer | Stage IVA Rectal Cancer and other conditionsUnited States
Clinical Trials on B-Cure Laser Pro and needles
-
Tel-Aviv Sourasky Medical CenterUnknown
-
Erika Carmel ltdNot yet recruitingDiabetic Foot UlcerIsrael
-
Scarborough Rouge HospitalRecruitingDiabetic Foot UlcerCanada
-
Erika Carmel ltdRecruitingHead and Neck Cancer | Mucositis | Radiotherapy Side EffectIsrael
-
Erika Carmel ltdTel-Aviv Sourasky Medical CenterRecruitingDiabetic Foot UlcerIsrael
-
Erika Carmel ltdHoly Family Hospital, Methuen, MACompletedRotator Cuff TearsIsrael
-
Hillel Yaffe Medical CenterUnknown
-
Erika Carmel ltdHoly Family Hospital, Nazareth, IsraelRecruiting
-
Hadassah Medical OrganizationUnknownDiabetic Foot UlcerIsrael
-
Al-Azhar UniversityEnrolling by invitationRoot Resorption of Maxillary IncisorsEgypt